Targeted Oncology™ & Oncology Nursing News® Community Case Forum™
Monday, November 17, 2025 | 5:45 - 8:30 PM CT
Hyatt Regency Milwaukee| Milwaukee, WI
CONNECT WITH THE COMMUNITY
The Community Case Forum is a special opportunity to gather IN-PERSON only.
No virtual options are available.
After arriving at registration check-in, you'll spend some time networking with peers while enjoying small plate refreshments and cocktails. Case-based discussions will follow the networking reception and the evening will adjourn by 8:30 PM.
Eligibility
Participants must be medical oncologists, hematologists, or advanced practice providers currently treating patients in a community practice setting. With prior approval from our registration team, a small number fellows may be eligible to attend.
Discussion Topics
You choose the topic that is best aligned for the patients you're seeing in your practice now. Our moderators will present case-based clinical profiles to generate discussion among participants around recent clinical data and potential treatment strategies.
Discussion Topics Include:
Exploring T-Cell Redirection Therapies in R/R LBCL
During this conversation we will explore two clinical cases, focusing on T-cell redirection therapy strategies including CAR T-cell therapies and bispecific antibodies for patients with R/R LBCL. We will examine one case in the second-line (2L) setting and one case in the third-line (3L) setting, highlighting the evolving landscape of these innovative approaches.
Moderated by: Nirav Shah, MD MS (Medical College of Wisconsin)
This discussion is only open to medical oncologists/hematologists.
Lung Cancer: Extensive-Stage SCLC
During this conversation, we will explore two clinical cases covering both the upfront and platinum-sensitive recurrent settings.
Moderated by: Ticiana Leal, MD (Winship Cancer Institute Emory University)
This discussion is only open to medical oncologists/hematologists.
Integrating New Approaches For Clear Cell RCC Into Practice
During this conversation, we will explore two cases that will allow us to share perspectives on integrating newer strategies into practice, including later line therapy for advanced RCC and TKI adverse event management.
Moderated by: Zita Lim, PA (MD Anderson)
This discussion is only open to advanced practice providers.
MARKET RESEARCH PARTICIPATION
Seating is limited, and registration will close when capacity is reached.
Reserve your seat today for the Targeted Oncology & Oncology Nursing News Community Case Forum.
The Value of Targeted Oncology Discussions
"Targeted Oncology provides educational materials that I can bring to my practice that can influence the way I practice each day. It’s a great opportunity to find out what peers are doing and see what the latest data shows as well." - Jason Levitz, MD
"Attending these discussions is a great way to get a sense of the latest and greatest. Right now in oncology, it’s hard to keep up with everything—there’s constantly new data coming out of conferences. Having someone put that into context - while you’re also able to discuss cases with community members and fellow physicians, is a great way to stay up to date to and educated." - Andrew Lipsky, MD
"Targeted Oncology discussions have influenced my clinical practice by helping me learn what other community oncologists are doing. I think it’s great to attend these forums where collectively we can learn from each other how to continue treating our patients the best way possible." - Eshan Patel, MD, MBA
Presented in Partnership With:
Targeted Healthcare Communications® — an MJH Life Sciences® Brand
259 Prospect Plains Rd., Building H, Monroe, NJ 08831
Copyright 2025 © Intellisphere, LLC. All Rights Reserved.